1981
DeVita responds to Post article.
DeVita V. DeVita responds to Post article. Historical Washington Post 1981, a27. PMID: 11646113.Peer-Reviewed Original ResearchDrug-Related Side Effects and Adverse ReactionsHuman ExperimentationHumansMass MediaMortalityNeoplasmsPatientsPharmaceutical PreparationsRiskRisk Assessment
1976
Treatment of hodgkin's disease using intensive chemotherapy followed by irradiation
Kun L, Devita V, Young R, Johnson R. Treatment of hodgkin's disease using intensive chemotherapy followed by irradiation. International Journal Of Radiation Oncology • Biology • Physics 1976, 1: 619-626. PMID: 824248, DOI: 10.1016/0360-3016(76)90143-7.Peer-Reviewed Original ResearchMeSH KeywordsAdultCobalt RadioisotopesDrug Therapy, CombinationDrug-Related Side Effects and Adverse ReactionsFemaleHodgkin DiseaseHumansMaleMechlorethaminePrednisoneProcarbazineRadioisotope TeletherapyRadiotherapy, High-EnergyVincristineConceptsHodgkin's diseaseResidual Hodgkin's diseaseTreatment-related morbidityUntreated Hodgkin's diseaseNormal tissue reactionsIntensive chemotherapyMarginal recurrenceCombination chemotherapyIncreased incidenceAutopsy examinationRadiation therapyTherapeutic efficacyFull doseMedical CollegeDiseasePatientsTissue reactionChemotherapyMarked enhancementIrradiation fieldMorbidityComplicationsRecurrenceTherapyIncidence
1973
Intensive chemotherapy for Hodgkin's disease: long-term complications.
DeVita V, Arseneau J, Sherins R, Canellos G, Young R. Intensive chemotherapy for Hodgkin's disease: long-term complications. National Cancer Institute Monograph 1973, 36: 447-54. PMID: 4744600.Peer-Reviewed Original ResearchAntineoplastic AgentsDrug Therapy, CombinationDrug-Related Side Effects and Adverse ReactionsEvaluation Studies as TopicFemaleFollicle Stimulating HormoneHodgkin DiseaseHumansImmunosuppression TherapyLuteinizing HormoneMaleMechlorethamineNeoplasmsPrednisoneProcarbazineTestosteroneTime FactorsVincristine
1972
Nonlymphomatous Malignant Tumors Complicating Hodgkin's Disease — Possible Association with Intensive Therapy
Arseneau J, Sponzo R, Levin D, Schnipper L, Bonner H, Young R, Canellos G, Johnson R, DeVita V. Nonlymphomatous Malignant Tumors Complicating Hodgkin's Disease — Possible Association with Intensive Therapy. New England Journal Of Medicine 1972, 287: 1119-1122. PMID: 5082192, DOI: 10.1056/nejm197211302872204.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAntineoplastic AgentsCarcinoma, Squamous CellCyclophosphamideDrug-Related Side Effects and Adverse ReactionsFemaleFibrosarcomaFollow-Up StudiesHead and Neck NeoplasmsHodgkin DiseaseHumansMaleMiddle AgedNeoplasm MetastasisNeoplasmsNeoplasms, Radiation-InducedNitrogen Mustard CompoundsPrednisoneProcarbazineRadiotherapyRemission, SpontaneousTime FactorsVincristineConceptsHodgkin's diseaseMalignant tumorsIntensive radiotherapyIntensive chemotherapyBiopsy-proven malignant tumorsTime of diagnosisSecond malignant tumorsRisk of developmentBasis of treatmentBasis of ageIntensive therapyCase recordsChemotherapyDiseasePatientsRadiotherapyTumorsGreater increaseSubgroupsRiskTherapyIncidenceDiagnosis